NewslettersCancer Stem Cell NewsHepatic Cell NewsBio-Responsive Au-miR-183 Inhibitor Enhances Immunotherapy in Hepatocellular Carcinoma by Inducing Immunogenic Cell DeathBy lbeveridge - March 18, 2024039Scientists constructed a bio-responsive Au-miR-183 inhibitor delivery system targeting liver cancer stem cells, and adopted the strategy of combining αPD-L1 immunotherapy.[Journal Of Controlled Release]Full Article